Clear Creek Financial Management, LLC
Source: SEC Form 13F · as of Mar 2026Clear Creek Financial Management, LLC holds 17 biotech & pharma companies tracked by BioSniper, totaling $20.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$20.6M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 4,694 | $4.3M |
| JNJJOHNSON & JOHNSON | 9,727 | $2.4M |
| ABBVAbbVie Inc. | 9,940 | $2.2M |
| GILDGILEAD SCIENCES, INC. | 15,215 | $2.1M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 6,147 | $1.7M |
| PMPhilip Morris International Inc | 9,042 | $1.5M |
| MRKMerck & Co., Inc. | 9,859 | $1.2M |
| NVONovo Nordisk A/S | 30,581 | $1.1M |
| MCKMcKesson Corporation | 1,058 | $915K |
| AMGNAMGEN INC | 1,887 | $664K |
| ABTABBOTT LABORATORIES | 5,645 | $580K |
| ZTSZoetis Inc. | 3,830 | $453K |
| NVSNovartis AG | 2,960 | $452K |
| PFEPFIZER INC | 13,103 | $368K |
| LEGNLegend Biotech Corp | 16,750 | $303K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 4,953 | $273K |
| RXRXRECURSION PHARMACEUTICALS, INC. | 42,953 | $132K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.